Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0097 | 0.9 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |